A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01

Primary Inclusion Criteria: 1. Have completed the LBRA01 trial. 2. Have achieved at least an ACR20 response at the end of LBRA01. Primary Exclusion Criteria: 1. Have switched NSAIDs due to worsening RA disease activity, used more than 10 mg/day of oral prednisone, or were given a corticosteroid injection during the last 30 days of LBRA01. 2. Required a new DMARD (not otherwise excluded in protocol LBRA01) to replace an ineffective one, or an additional DMARD (not to exceed 2 DMARDs in total) within the last 60 days of LBRA01. 3. Used prohibited medications during their participation in LBRA01. These medications include the following: * Other investigational agents. * Biologic response modifiers * Cyclophosphamide. * Corticosteroid injections (except 1 injection of up to 40 mg of prednisone into an inflamed joint or intramuscularly every 6 months). * 2 new DMARDs. * 1 new DMARD plus high dose prednisone \>10 mg/day.